Analysts’ Viewpoint on Varicose Veins Treatment Market Scenario
The global varicose veins treatment market is constantly evolving, as prominent players adopt growth strategies such as mergers & acquisitions, new product launches, and partnerships. Growth of the global varicose veins treatment market can be ascribed to rise in prevalence and awareness of varicose veins coupled with favorable reimbursement policies. Preference for compression devices, stockings, and garments has increased for varicose veins treatment. These devices help reduce symptoms of venous insufficiency and improve blood circulation by exerting gentle pressure on the legs. Venture funding and geographical expansions are likely to create significant opportunities for existing market participants and new market entrants in the near future. The global varicose veins treatment devices market players should focus on continued investment in R&D to introduce innovative products in the market.
Medical treatments for varicose veins include self-care such as compression stockings, exercise, and medical procedures/surgeries along with devices. Various methods such as endovenous ablation (a varicose veins surgery), sclerotherapy/adhesion injection, ligation/stripping, and supportive treatment are used for varicose veins treatment.
An article published in the Journal of Family Medicine and Primary Care stated that the prevalence of varicose veins varies from 10% to 60% of the population across the world. Varicose veins is a common chronic venous disorder that affects 20% to 60% of adults, globally. The prevalence is around 4,500 cases per 100,000 individuals and around 23% of adults have varicose veins in the U.S. The incidence is higher in Asia Pacific at 30% than in the West.
Rise in prevalence of small and greater saphenous vein, reticular varicose veins, and genital area varicose veins have induced people to be more aware and educated about varicose veins warning signals and the importance of prompt response. Technological advancements in varicose veins treatment devices propel the global market. Radiofrequency (RF) endovenous ablation is one of the several minimally invasive treatments used for varicose veins. RF procedure involves the use of ultrasound to guide a radiofrequency catheter.
Surgical removal is one of the several treatments used for varicose veins. In the procedure, infrared medical vein finders are used to draw a map of veins, arteries, and tissues to avoid complications during treatment.
Mechanochemical Ablation (MOCA) is a non-thermal, non-tumescent technique used for the treatment of incompetent saphenous vein. Such technological advancements in varicose veins treatment are driving the market. Additionally, in August 2019, Surekha Varicose Veins Clinic in Mumbai launched India’s first-ever Cryo Laser and Cryo Sclerotherapy (CLaCS) for the treatment of small varicose veins in the leg and spider veins (spider vein treatment). Sclerotherapy is a minimally invasive procedure used for spider vein treatment, usually in the legs.
COVID-19 has had a negative effect on the varicose veins treatment devices market. Several varicose veins surgeries were postponed or canceled, as these fall under the elective or non-urgent procedures category. Reduction in the number of surgeries or procedures for the treatment of varicose veins due to traveling restrictions also hit product sales. For instance, AngioDynamics' net sales declined by 2.4% in 2020, as compared to 2019. Venous registry volumes reduced fivefold in India in the first quarter of 2020, as compared to a similar period in 2019. In 2020, varicose veins treatment surgeries declined by 30% in public hospitals in Australia, as compared to those in 2019. Recently, clinics and hospitals have resumed services for non-emergent cases and backlogged procedures for varicose veins. This, in turn, is anticipated to drive demand for devices in the near future.
In terms of product, the compression devices/garments segment held the largest global varicose veins treatment market share in 2021. The segment is projected to grow at a rapid pace during the forecast period. This is ascribed to increase in the use of compression stockings to effectively manage and treat varicose veins in the early stages. Preference for compression stockings for varicose veins treatment is on the rise, as these help to ease symptoms and pain and improve the appearance of varicose veins. This is expected to drive the segment during the forecast period.
The supportive treatment segment held a prominent share of the global varicose veins treatment market in 2021, and the trend is anticipated to continue during the forecast period. This is ascribed to increase in preference for compression stockings and rise in consumption along with the repetitive purchase of compression socks. Compression stockings have been a standard treatment for varicose veins for several decades and are still prescribed as the first-line therapy to manage symptoms and prevent the progression of chronic venous insufficiency.
The rate of hospitalization for varicose veins treatment and the range of services offered by hospitals at a single site is on the rise. Ambulatory Surgery Centers (ASCs) can improve quality and customer service, while simultaneously reducing healthcare costs. The ASC vertical is ahead of the curve in identifying favorable avenues to improve healthcare delivery. Increase in the number of hospitals and ASCs along with comparatively higher performance and adoption of varicose veins surgeries in these settings is expected to augment the segment.
North America accounted for the largest share of the global varicose veins treatment market in 2021, and the trend is expected to continue during the forecast period. Growth of the market in the region is ascribed to rise in the burden of varicose veins and higher rate of adoption of varicose vein treatment devices and procedures in the U.S. and Canada are also boosting the market in North America. The region also has a robust presence of prominent manufacturers, such as AngioDynamics, Inc., Boston Scientific Corporation, DJO, LLC, Viatris, Inc., and Teleflex Incorporated, which facilitates early market access and easier availability of products.
Asia Pacific is likely to be a lucrative market during the forecast period due to surge in geriatric population, increase in incidence of varicose veins, rise in awareness about advanced treatment options, and surge in adoption of minimally invasive procedures for the treatment of varicose veins. For instance, an article published in China Daily in July 2021 indicated that around 120 million patients in China suffered from varicose veins of the lower extremities in 2021, of which more than 80 million were women. The primary treatments followed in the country are drug-based therapy, compression therapy, sclerotherapy (injections that destroy abnormal blood vessels), and varicose veins surgery.
The varicose veins treatment market research report concludes with the company profiles section that includes key information about the major players in the global varicose veins treatment market. Market participants focus on strategies such as new product launches, mergers & acquisitions (M&As), and partnerships to strengthen their market position. AngioDynamics, Inc., Boston Scientific Corporation (BTG International Inc.), DJO, LLC (Enovis Corporation), Essity Aktiebolag (publ) (BSN Medical), F Care Systems NV, Medtronic plc, Miravas (IPSA Group), Mylan N.V. (Viatris Inc.), SIGVARIS Group, Teleflex Incorporated, VVT Medical, and WONTECH Co., Ltd. are the prominent players operating in the global market.
In June 2022, VVT Medical signed a distribution agreement with Getz Healthcare, a medical technology distributor in Asia Pacific. According to the terms of the agreement, Getz will distribute VVT Medical’s products in Australia, New Zealand, and Hong Kong.
In November 2020, Pfizer, Inc. completed the transaction to spin off its Upjohn Business and combined it with Mylan N.V. to form Viatris, Inc. The merger was aimed to form a new name that would differentiate the new company and explain the company’s position in the global healthcare industry.
In October 2019, AngioDynamics, Inc. acquired Eximo Medical, Ltd., a medical device company, and its proprietary 355nm wavelength laser-technology platform, to bring a remarkable, foundational technology to the company’s portfolio, which would change the way caregivers deliver treatment to patients with Peripheral Artery Disease (PAD). With this acquisition, the company expanded its laser device product portfolio.
Each of these players has been profiled in the varicose veins treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 1.5 Bn |
|
Market Forecast Value in 2031 |
More than US$ 2.4 Bn |
|
Compound Annual Growth Rate (CAGR) |
4.8% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value & Units for Volume |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. The volume analysis has been provided for the product segment at global and regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global varicose veins treatment market was valued at US$ 1.5 Bn in 2021
The global varicose veins treatment market is projected to reach more than US$ 2.4 Bn by 2031
The global varicose veins treatment market is anticipated to grow at a CAGR of 4.8% from 2022 to 2031
Rise in prevalence and awareness about varicose veins, favorable reimbursement policies, and technological advancements in varicose veins treatment
The compression devices/garments segment accounted for more than 48% share of the global varicose veins treatment market in 2021
North America is expected to account for major share of the global varicose veins treatment market during the forecast period
AngioDynamics, Inc., Boston Scientific Corporation (BTG International Inc.), DJO, LLC (Enovis Corporation), Essity Aktiebolag (publ) (BSN Medical), F Care Systems NV, Medtronic plc, Miravas (IPSA Group), Mylan N.V. (Viatris Inc.), SIGVARIS Group, Teleflex Incorporated, VVT Medical, and WONTECH Co., Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Varicose Veins Treatment Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
5. Key Insights
5.1. Key Industry Events
5.2. Epidemiology of Varicose Veins Globally with Key Countries
5.3. Overview of Treatment and Management of Varicose Veins
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Varicose Veins Treatment Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value & Volume Forecast, by Product, 2017–2031
6.3.1. Ablation Devices
6.3.1.1. Radiofrequency Ablation/Thermal Ablation
6.3.1.2. Laser Ablation Devices
6.3.1.3. Ultrasound Ablation Devices
6.3.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
6.3.3. Compression Devices/Garments
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Treatment Type, 2017–2031
7.3.1. Endovenous Ablation
7.3.2. Sclerotherapy/Adhesion Injection
7.3.3. Ligation/Stripping
7.3.4. Supportive Treatment
7.4. Market Attractiveness Analysis, by Treatment Type
8. Global Varicose Veins Treatment Market Analysis and Forecast, by Disease Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Disease Type, 2017–2031
8.3.1. Greater Saphenous Varicose Veins
8.3.2. Small Saphenous Varicose Veins
8.3.3. Others
8.4. Market Attractiveness Analysis, by Disease Type
9. Global Varicose Veins Treatment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Ambulatory Surgical Centers
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Varicose Veins Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Varicose Veins Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product, 2017–2031
11.2.1. Ablation Devices
11.2.1.1. Radiofrequency Ablation/Thermal Ablation
11.2.1.2. Laser Ablation Devices
11.2.1.3. Ultrasound Ablation Devices
11.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
11.2.3. Compression Devices/Garments
11.2.4. Others
11.3. Market Value Forecast, by Treatment Type, 2017–2031
11.3.1. Endovenous Ablation
11.3.2. Sclerotherapy/Adhesion Injection
11.3.3. Ligation/Stripping
11.3.4. Supportive Treatment
11.4. Market Value Forecast, by Disease Type, 2017–2031
11.4.1. Greater Saphenous Varicose Veins
11.4.2. Small Saphenous Varicose Veins
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals & Ambulatory Surgical Centers
11.5.2. Specialty Clinics
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Treatment Type
11.7.3. By Disease Type
11.7.4. By End-user
11.7.5. By Country
12. Europe Varicose Veins Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product, 2017–2031
12.2.1. Ablation Devices
12.2.1.1. Radiofrequency Ablation/Thermal Ablation
12.2.1.2. Laser Ablation Devices
12.2.1.3. Ultrasound Ablation Devices
12.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
12.2.3. Compression Devices/Garments
12.2.4. Others
12.3. Market Value Forecast, by Treatment Type, 2017–2031
12.3.1. Endovenous Ablation
12.3.2. Sclerotherapy/Adhesion Injection
12.3.3. Ligation/Stripping
12.3.4. Supportive Treatment
12.4. Market Value Forecast, by Disease Type, 2017–2031
12.4.1. Greater Saphenous Varicose Veins
12.4.2. Small Saphenous Varicose Veins
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals & Ambulatory Surgical Centers
12.5.2. Specialty Clinics
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Treatment Type
12.7.3. By Disease Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Varicose Veins Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product, 2017–2031
13.2.1. Ablation Devices
13.2.1.1. Radiofrequency Ablation/Thermal Ablation
13.2.1.2. Laser Ablation Devices
13.2.1.3. Ultrasound Ablation Devices
13.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
13.2.3. Compression Devices/Garments
13.2.4. Others
13.3. Market Value Forecast, by Treatment Type, 2017–2031
13.3.1. Endovenous Ablation
13.3.2. Sclerotherapy/Adhesion Injection
13.3.3. Ligation/Stripping
13.3.4. Supportive Treatment
13.4. Market Value Forecast, by Disease Type, 2017–2031
13.4.1. Greater Saphenous Varicose Veins
13.4.2. Small Saphenous Varicose Veins
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals & Ambulatory Surgical Centers
13.5.2. Specialty Clinics
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Treatment Type
13.7.3. By Disease Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Varicose Veins Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product, 2017–2031
14.2.1. Ablation Devices
14.2.1.1. Radiofrequency Ablation/Thermal Ablation
14.2.1.2. Laser Ablation Devices
14.2.1.3. Ultrasound Ablation Devices
14.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
14.2.3. Compression Devices/Garments
14.2.4. Others
14.3. Market Value Forecast, by Treatment Type, 2017–2031
14.3.1. Endovenous Ablation
14.3.2. Sclerotherapy/Adhesion Injection
14.3.3. Ligation/Stripping
14.3.4. Supportive Treatment
14.4. Market Value Forecast, by Disease Type, 2017–2031
14.4.1. Greater Saphenous Varicose Veins
14.4.2. Small Saphenous Varicose Veins
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals & Ambulatory Surgical Centers
14.5.2. Specialty Clinics
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Treatment Type
14.7.3. By Disease Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value & Volume Forecast, by Product, 2017–2031
15.2.1. Ablation Devices
15.2.1.1. Radiofrequency Ablation/Thermal Ablation
15.2.1.2. Laser Ablation Devices
15.2.1.3. Ultrasound Ablation Devices
15.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
15.2.3. Compression Devices/Garments
15.2.4. Others
15.3. Market Value Forecast, by Treatment Type, 2017–2031
15.3.1. Endovenous Ablation
15.3.2. Sclerotherapy/Adhesion Injection
15.3.3. Ligation/Stripping
15.3.4. Supportive Treatment
15.4. Market Value Forecast, by Disease Type, 2017–2031
15.4.1. Greater Saphenous Varicose Veins
15.4.2. Small Saphenous Varicose Veins
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals & Ambulatory Surgical Centers
15.5.2. Specialty Clinics
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Treatment Type
15.7.3. By Disease Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis/Ranking, by Company, 2021
16.3. Company Profiles
16.3.1. AngioDynamics, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Boston Scientific Corporation (BTG International Inc.)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. DJO, LLC (Enovis Corporation)
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Essity Aktiebolag (publ) (BSN Medical)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. F Care Systems NV
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Medtronic plc
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Miravas (IPSA Group)
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. Mylan N.V. (Viatris Inc.)
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. SIGVARIS Group
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. Teleflex Incorporated
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. VVT Medical
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview
16.3.12. WONTECH Co., Ltd.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. SWOT Analysis
List of Tables
Table 01: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031
Table 03: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031
Table 04: Global Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031
Table 05: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 06: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031
Table 07: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 09: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 11: North America Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031
Table 12: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031
Table 13: North America Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031
Table 14: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 15: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031
Table 16: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Europe Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031
Table 20: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031
Table 21: Europe Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031
Table 22: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 23: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031
Table 24: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 27: Asia Pacific Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031
Table 28: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031
Table 29: Asia Pacific Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031
Table 30: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 31: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031
Table 32: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 33: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 34: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 35: Latin America Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031
Table 36: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031
Table 37: Latin America Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031
Table 38: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 39: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031
Table 40: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 41: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 42: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 43: Middle East & Africa Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031
Table 44: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031
Table 45: Middle East & Africa Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031
Table 46: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 47: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031
Table 48: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031
Figure 02: Global Varicose Veins Treatment Market Attractiveness Analysis, by Product 2022–2031
Figure 03: Global Varicose Veins Treatment Market (US$ Mn), by Ablation Devices, 2017–2031
Figure 04: Global Varicose Veins Treatment Market (US$ Mn), by Catheters/Kits for Sclerotherapy & Adhesion Injection, 2017–2031
Figure 05: Global Varicose Veins Treatment Market (US$ Mn), by Compression Devices/Garments, 2017–2031
Figure 06: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031
Figure 07: Global Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031
Figure 08: Global Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031
Figure 09: Global Varicose Veins Treatment Market (US$ Mn), by Endovenous Ablation, 2017–2031
Figure 10: Global Varicose Veins Treatment Market (US$ Mn), by Sclerotherapy/Adhesion Injection, 2017–2031
Figure 11: Global Varicose Veins Treatment Market (US$ Mn), by Ligation/Stripping, 2017–2031
Figure 12: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031
Figure 13: Global Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031
Figure 14: Global Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031
Figure 15: Global Varicose Veins Treatment Market (US$ Mn), by Greater Saphenous Varicose Veins, 2017–2031
Figure 16: Global Varicose Veins Treatment Market (US$ Mn), by Small Saphenous Varicose Veins, 2017–2031
Figure 17: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031
Figure 18: Global Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 19: Global Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 20: Global Varicose Veins Treatment Market (US$ Mn), by Hospitals & Ambulatory Surgical Centers, 2017–2031
Figure 21: Global Varicose Veins Treatment Market (US$ Mn), by Specialty Clinics, 2017–2031
Figure 22: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031
Figure 23: Global Varicose Veins Treatment Market Analysis and Forecast, by Region, 2021 and 2031
Figure 24: Global Varicose Veins Treatment Market Attractiveness Analysis, by Region, 2022–2031
Figure 25: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 26: North America Varicose Veins Treatment Market Analysis and Forecast, by Country, 2021 and 2031
Figure 27: North America Varicose Veins Treatment Market Attractiveness Analysis, by Country, 2022–2031
Figure 28: North America Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031
Figure 29: North America Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031
Figure 30: North America Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031
Figure 31: North America Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031
Figure 32: North America Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031
Figure 33: North America Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031
Figure 34: North America Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 35: North America Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 36: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 37: Europe Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 38: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 39: Europe Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031
Figure 40: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031
Figure 41: Europe Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031
Figure 42: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031
Figure 43: Europe Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031
Figure 44: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031
Figure 45: Europe Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 46: Europe Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 47: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 48: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 49: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 50: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031
Figure 51: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031
Figure 52: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031
Figure 53: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031
Figure 54: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031
Figure 55: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031
Figure 56: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 57: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 58: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 59: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 60: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 61: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031
Figure 62: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031
Figure 63: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031
Figure 64: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031
Figure 65: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031
Figure 66: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031
Figure 67: Latin America Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 68: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 69: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031
Figure 70: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 71: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 72: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031
Figure 73: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031
Figure 74: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031
Figure 75: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031
Figure 76: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031
Figure 77: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031
Figure 78: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 79: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 80: Global Varicose Veins Treatment Market Share Analysis/Ranking, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Varicose Veins Treatment Market
